MXPA03003911A - Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas. - Google Patents

Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas.

Info

Publication number
MXPA03003911A
MXPA03003911A MXPA03003911A MXPA03003911A MXPA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A MX PA03003911 A MXPA03003911 A MX PA03003911A
Authority
MX
Mexico
Prior art keywords
enhanced
excipient
fungal powder
excipient properties
properties
Prior art date
Application number
MXPA03003911A
Other languages
English (en)
Inventor
Joann Adele Brooks
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MXPA03003911A publication Critical patent/MXPA03003911A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta descrito un polvo para el cuerpo. El polvo para el cuerpo incluye un agente anti-fungal topico en combinacion con por lo menos dos excipientes. Un excipiente es un material en particulas de nitrido de boro recubierto con un compuesto de silicona. El otro excipiente es una fragancia atrapada molecularmente dentro del compuesto de ciclodextrina.
MXPA03003911A 2002-05-30 2003-05-02 Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas. MXPA03003911A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/161,157 US6824763B2 (en) 2002-05-30 2002-05-30 Anti-fungal powder having enhanced excipient properties

Publications (1)

Publication Number Publication Date
MXPA03003911A true MXPA03003911A (es) 2004-10-15

Family

ID=29583367

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003911A MXPA03003911A (es) 2002-05-30 2003-05-02 Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas.

Country Status (2)

Country Link
US (1) US6824763B2 (es)
MX (1) MXPA03003911A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598073A1 (de) * 2004-02-02 2005-11-23 Universitätsklinikum Freiburg Korianderöl und dieses enthaltende Zubereitungen mit antimikrobieller und antiphlogistischer Wirkung und deren Verwendung
WO2007047253A2 (en) * 2005-10-11 2007-04-26 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
CA2647374A1 (en) * 2005-10-24 2007-05-03 Staval Pharma, Ltd. Method for treating/controlling/killing fungi and bacteria
US8663665B2 (en) 2006-03-02 2014-03-04 Momentive Performance Materials Inc. Anti-chafing compositions comprising boron nitride
US20080057009A1 (en) * 2006-08-30 2008-03-06 Michael Brett Grunhaus Talc-based sand removing sun care powder.
US10149910B2 (en) 2007-03-01 2018-12-11 The Procter & Gamble Plaza Compositions and/or articles comprising cyclodextrin complexing material
US11090250B2 (en) 2007-03-01 2021-08-17 The Procter & Gamble Company Compositions and/or articles comprising cyclodextrin complexing material
US7790202B1 (en) * 2007-04-09 2010-09-07 Martell Helen D Multi-purpose skin composition
US20090149361A1 (en) * 2007-12-11 2009-06-11 Emily Kathleen Adkison Personal cleansing kit for promoting relaxation and sleep, reducing stress and decreasing muscle tightness
ES2838524T3 (es) * 2012-04-25 2021-07-02 Oreal Aceite esencial de Achillea, composición cosmética que lo comprende y sus usos
US11458049B2 (en) 2016-09-06 2022-10-04 The Procter & Gamble Company Absorbent articles including perfume and cyclodextrins
MX2019002544A (es) 2016-09-06 2019-07-01 Procter & Gamble Composiciones en aerosol.
CA3035350C (en) 2016-09-06 2023-05-23 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising a hydrophilic perfume compound complexed in a cyclodextrin
US10758476B1 (en) * 2017-09-18 2020-09-01 Type A Brands, Llc Deodorant with sweat-activated technology
CN108066228B (zh) * 2018-02-09 2020-06-12 杭州纳美智康科技有限公司 一种保湿抗菌沐浴露及其制备方法
CN112587462B (zh) * 2021-01-08 2023-04-14 中华全国供销合作总社南京野生植物综合利用研究所 一种芫荽提取物的应用、抗紫外抗氧化美白化妆品及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818614A (en) 1985-07-29 1989-04-04 Shiseido Company Ltd. Modified powder
US4801445A (en) 1985-07-29 1989-01-31 Shiseido Company Ltd. Cosmetic compositions containing modified powder or particulate material
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
US4880774A (en) 1987-04-14 1989-11-14 Kurita Water Industries, Ltd. Sustained release aromatic
IT1203968B (it) 1987-04-24 1989-02-23 Bononi Ricerca Complessi di b-ciclodestrina ad attivita' antimicotica
AU608891B2 (en) 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US5476852A (en) 1989-05-03 1995-12-19 Janssen Pharmaceutica N.V. Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
US5658956A (en) 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5246780A (en) 1991-08-29 1993-09-21 L'oreal Coated particle for use in cosmetic preparations and method
US5324718A (en) 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
FR2695558B1 (fr) 1992-09-11 1994-10-21 Oreal Composition cosmétique contenant des particules solides revêtues avec un polymère amphotère.
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JPH07115003A (ja) * 1993-10-15 1995-05-02 Matsushita Electric Ind Co Ltd チップ抵抗器の製造方法
TW438601B (en) 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
IL115693A (en) 1994-10-25 2000-08-13 Revlon Consumer Prod Corp Cosmetic compositions with improved transfer resistance
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JPH11502495A (ja) 1995-01-31 1999-03-02 ローベルト ボツシユ ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 疎水化された表面を有するセラミック粉末、その製造方法および使用法
US5665364A (en) 1995-07-24 1997-09-09 The Procter & Gamble Company Compositions for topical delivery of active ingredients
US5607980A (en) 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US5723420A (en) 1996-03-04 1998-03-03 The Procter & Gamble Company Personal cleansing bar compositions which contain a fragrance-releasing complex for improved fragrance delivery
CA2250962C (en) 1996-04-04 2003-06-03 Nanophase Technologies Corporation Siloxane star-graft polymers, ceramic powders coated therewith and method of preparing coated ceramic powders
JPH11508612A (ja) 1996-05-02 1999-07-27 ザ、プロクター、エンド、ギャンブル、カンパニー 分散した界面活性剤錯体を含む局所用組成物
WO1998011877A1 (en) * 1996-09-18 1998-03-26 Dragoco, Inc. Liposome encapsulated active agent dry powder composition
US5993967A (en) 1997-03-28 1999-11-30 Nanophase Technologies Corporation Siloxane star-graft polymers, ceramic powders coated therewith and method of preparing coated ceramic powders
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
DE69810803T2 (de) 1997-10-24 2003-12-24 The Procter & Gamble Co., Cincinnati Reinigungs- und konditionierungsgegenstand für die haut oder das haar, mit erhöhter duftfreisetzung
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU5146600A (en) 1999-05-27 2000-12-18 Procter & Gamble Company, The Topical compositions providing improved treatment of skin or scalp fungal infections
DE60041699D1 (de) 1999-06-25 2009-04-16 Procter & Gamble Topische antimikrobielle zusammensetzungen
AU5975700A (en) 1999-07-02 2001-01-22 Janssen Pharmaceutica N.V. Nasal formulation of an antifungal
US6514504B1 (en) * 1999-08-18 2003-02-04 The Procter & Gamble Company Discontinuous films from skin care compositions
GB9920167D0 (en) 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
US7208463B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions

Also Published As

Publication number Publication date
US20030224063A1 (en) 2003-12-04
US6824763B2 (en) 2004-11-30

Similar Documents

Publication Publication Date Title
MXPA03003911A (es) Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas.
EP1507556A4 (en) CALICHEAMICINE DERIVATIVE VECTOR-TYPE CONJUGATES
PL388076A1 (pl) Doustna postać dawki o przedłużonym uwalnianiu oksykodonu i jej zastosowanie
IL215981A0 (en) An antibody-drug conjugate, an article or manufacture and pharmaceutical compositions comprising thereof
MXPA03009797A (es) ANTICUERPOS PARA BLOQUEO DE PROTEiNA CRIPTO Y USO DE LOS MISMOS.
DE60208177D1 (de) Propylenpolymerzusammensetzung, formkörper und polyolefincopolymer
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
DE602004015134D1 (de) Saugfähige artikel mit metallbeladenen nanoteilchen
BR9915457B1 (pt) composições de moldagem, uso e artigo.
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
IL157965A0 (en) Cytotoxic cd44 antibody immunoconjugates
CA103970S (en) Blister pack
DE60314265D1 (de) Pharmazeutische zusammensetzungen mit modafinil
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
GB2368525B (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
HRP20050142A2 (en) Steroid conjugates, preparation thereof and the use thereof
CA105215S (en) Packaging with cosmetic composition
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
ATE286748T1 (de) Medizinische verbandmittel enthaltend zinkoxid mit antimikrobieller wirkung
USD474841S1 (en) Dosage device
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug

Legal Events

Date Code Title Description
FG Grant or registration